Latest European Patent Office Stories
BRUSSELS and MUNICH, February 26, 2015 /PRNewswire/ -- - Patent filings at the European Patent Office (EPO) reach all-time high in 2014
MUNICH, January 22, 2015 /PRNewswire/ -- - Europe's most prestigious innovation prize celebrates its tenth year - The European Patent Office to present
- Patent Protection for NB32 for Treating Insulin Resistance - SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that the U.S.
TAIPEI, July 29, 2014 /PRNewswire/ -- Apex Medical Corporation (Apex, TWSE: 4106), a leading player in the Respiratory Therapy and Pressure Area Care sectors, announces that it is appealing
JENA, Germany, July 23, 2014 /PRNewswire/ -- Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced
Copan’s attack was blown away by the District Court Düsseldorf. Guilford, ME (PRWEB) July 17, 2014 At an oral hearing on June 24, 2014 (case no.
HAMM, Germany, May 9, 2014 /PRNewswire/ -- In December 2011, Align Technology filed a patent infringement lawsuit against Ortho Caps GmbH (maker of orthocaps(R) aligners)
--PDL's Revolutionary Antibody Technology Provided Basis for Eight Successful Drugs Currently on the Market-- INCLINE VILLAGE, Nev., May 6, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
FALLS CHURCH, Va., April 21, 2014 /PRNewswire-USNewswire/ -- Acentia, a premier provider of technology and management solutions, today announced it was awarded a 1-year, $2.5-million contract
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.